Evidence map›Paper›PMID 37655643›Full record

ArticleNanoscale2023

A safer framework to evaluate characterization technologies of exhaled biologic materials using electrospun nanofibers.

David T Evans, Dalton J Nelson, Megan E Pask, Frederick R Haselton

Abstract read
In one paragraph

Article in Nanoscale, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

David T EvansDepartment of Biomedical Engineering, 5824 Stevenson Center, Vanderbilt University, Nashville, TN 37232, USA. rick.haselton@vanderbilt.edu.ORCID http://orcid.org/0000-0002-5685-6647
Dalton J NelsonDepartment of Biomedical Engineering, 5824 Stevenson Center, Vanderbilt University, Nashville, TN 37232, USA. rick.haselton@vanderbilt.edu.ORCID http://orcid.org/0000-0002-6912-2052
Megan E PaskDepartment of Biomedical Engineering, 5824 Stevenson Center, Vanderbilt University, Nashville, TN 37232, USA. rick.haselton@vanderbilt.edu.ORCID http://orcid.org/0009-0001-2896-5731
Frederick R HaseltonDepartment of Biomedical Engineering, 5824 Stevenson Center, Vanderbilt University, Nashville, TN 37232, USA. rick.haselton@vanderbilt.edu.ORCID http://orcid.org/0000-0003-4282-5222

Funding

Point-of-Care RT-PCR System to Inform COVID-19 and Respiratory Illness DecisionsR01AI157827 · NIAID · VANDERBILT UNIVERSITY · PI Frederick R Haselton, Jonathan E Schmitz · 2020 to 2026
$4.7M
NIAID NIH HHS R01 AI157827
6 · The paper itself

Abstract

Exhaled biologic material is the source for the spread of many respiratory tract infections. To avoid the high-level of biosafety required to manage dangerous pathogens, we developed a safer framework using the endogenous surrogate targets RNase P and

Indexed as

Biological ProductsNanofibersExhalationHumansRespirationRibonuclease PBiological ProductsRibonuclease P

Identifiers

PMID37655643
PMCPMC10530601

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.